Emergency Medicine Doctors in Lawrenceburg, TN Accepting Medicare

4 Emergency Medicine doctors found. Showing 1 - 4

Dr. Krystal V Garcia, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1607 S Locust Ave, Lawrenceburg, TN 38464 Phone: 912-539-5587

William L Bell Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1607 S Locust Ave, Lawrenceburg, TN 38464 Phone: 931-762-6571    Fax: 865-291-3228

Charles Love, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1607 S Locust Ave, Lawrenceburg, TN 38464 Phone: 931-762-6571    Fax: 865-291-3228

Dan S Powell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1607 S Locust Ave, Lawrenceburg, TN 38464 Phone: 931-762-6571    Fax: 865-291-3228

News Archive

ZELTIQ Aesthetics' CoolCurve+ applicator to be highlighted at EMAA 2012

ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at the 8th European Masters in Aesthetics & Anti-Aging (EMAA) in Paris, October 12-14, 2012, and will highlight CoolCurve+, the newest addition to the applicator platform for the CoolSculpting System.

Survey shows web users access social media sites in emergency situations

A new American Red Cross survey shows many web users would turn to social media to seek help for themselves or others during emergencies—and they expect first responders to be listening.The online survey asked 1,058 adults about their use of social media sites in emergency situations. It found that if they needed help and couldn't reach 9-1-1, one in five would try to contact responders through a digital means such as e-mail, websites or social media.

Congenital heart disease patients more likely to suffer from atrial fibrillation

Patients with congenital heart disease are up to 85 times more likely to suffer from atrial fibrillation as adults. The researchers behind a study, published in the journal Circulation, are now advocating more frequent screenings of the most vulnerable groups.

Dyax to discontinue ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax Corp. announced today the decision to discontinue the Company's Phase 2 trial investigating ecallantide in the acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema based upon the results of an interim analysis.

Read more Medical News

› Verified 6 days ago